S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|MannKind Corporation Announces FDA Approval of AFREZZA(R); A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes|
|MannKind Announces Closing of Global Licensing Agreement With Sanofi|
|MannKind Corporation to Hold 2014 Second Quarter Financial Results Conference Call on August 11, 2014|
|MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference|
|MannKind Announces Receipt of $150 Million Licensing Upfront Payment|
|Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin|
|Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin|
|UPDATE: Sanofi, MannKind to commercialize Afrezza insulin therapy|
|Sanofi, MannKind to commercialize Afrezza insulin therapy|
|MannKind Corporation Reports 2014 Second Quarter Financial Results|
Click above to view more mutual fund data and stats for mnkd - MannKind Corp.